PCRX SC TO-T: Acquisition
Filed with the SEC on · accession 0001140361-26-044347
PCRX filed a SC TO-T (sc to-t) with the SEC on Nov 17, 2026. Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., completed its tender offer for Pacira BioSciences at $36.50 per share, with approximately 66.46% of shares tendered.
Summary of the filing
Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., completed its tender offer for Pacira BioSciences at $36.50 per share, with approximately 66.46% of shares tendered. The merger was consummated on November 17, 2026, making Pacira a wholly owned subsidiary of Viatris, and Pacira shares will be delisted from Nasdaq.
Key details
✦ Ask GOAX AI about this filing — what it means for PCRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PCRX?
Click hereFrequently asked questions
What did PCRX file with the SEC on Nov 17, 2026?
PCRX filed a SC TO-T (Acquisition). Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., completed its tender offer for Pacira BioSciences at $36.50 per share, with approximately 66.46% of shares tendered. The merger was consummated on November 17, 2026, making Pacira a wholly owned subsidiary of Viatris, and Pacira shares will be delisted from Nasdaq.
What does a acquisition mean for PCRX stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a SC TO-T?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SC TO-T (sc to-t): A report the company filed with the SEC (the US market regulator).
Other PCRX SEC filings
- SC TO-T · Tender offerNov 12, 2026
- 8-K · Legal settlementNov 12, 2026
- 8-K · AcquisitionNov 5, 2026
- 10-Q · Material agreementNov 5, 2026
- SC TO-T · Tender offerOct 30, 2026
- SCHEDULE 13G/A · SEC filingOct 30, 2026
- SCHEDULE 13D/A · Activist campaignOct 13, 2026
- 8-K · SEC filingOct 8, 2026
- 8-K · SEC filingAug 4, 2026
- 10-Q · Executive departureAug 4, 2026
Get alerts when PCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days